Allarity Therapeutics, Inc. Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements
Allarity Therapeutics, Inc. (ALLR) reported Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements of 13.92 thousand shares for the 1-month period ending 2017-02-24, per its 10-K filed 2023-03-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements · last filed 2023-03-13
- 2017-02-24: Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements 1 month 13.92K shares.
- 2016-02-18: Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements 1 month 12.68K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements 1 month |
|---|---|
| 2017-02-24 | 13.92K shares 10-K · filed 2023-03-13 |
| 2016-02-18 | 12.68K shares 10-K · filed 2023-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |